NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects Prescription Drug Misuse ✖Remove constraint Subjects: Prescription Drug Misuse Copyright Public domain ✖Remove constraint Copyright: Public domain

2. Opioid use in Medicare Part D remains concerning

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
Analgesics, Opioid -- economics
Fentanyl -- adverse effects
Prescription Drug Diversion
Humans
United States
United States. Department of Health and Human Services.

3. Opioids in Ohio Medicaid: review of extreme use and prescribing

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Inappropriate Prescribing
Medicaid
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- prevention & control
Prescription Drug Misuse
Analgesics, Opioid -- administration & dosage
Humans
Ohio
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

4. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

5. Social Security disability: action needed to help agency staff understand and follow policies related to prescription opioid misuse : report to the Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 2020
Subject(s):
Insurance, Disability
Opioid-Related Disorders
Prescription Drug Misuse
Government Regulation
United States
United States. Social Security Administration